3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
2
Seroma
1
Rectal Diseases
1
Prostatic Neoplasms
1
Patient Satisfaction
1
Pancreatitis
1
Pancreatic Neoplasms
1
Pain, Postoperative
1
Neoplasms by Site
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Interventions
Fluorouracil
4
Oxaliplatin
3
Leucovorin
3
Irinotecan
3
Bevacizumab
3
5,10-methylenetetrahydrofolic acid
3
Colonoscopy
2
Capecitabine
2
Bisacodyl
2
trametinib
1
spartalizumab
1
pralsetinib
1
nazartinib
1
napabucasin
1
guadecitabine
1
canakinumab
1
Ursodeoxycholic Acid
1
Tinzaparin
1
Suction
1
Simvastatin
1
Radiotherapy
1
Polyethylene Glycols
1
Pemetrexed
1
Oviposition
1
Ocoxin
1
Mass Screening
1
Levoleucovorin
1
Drainage
1
Cyclophosphamide
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Intestinal Neoplasms
×
Drainage
×
Clear all
NCT01269567
2026-05-14
GRECCAR 5
University Hospital, Bordeaux
Phase 3
Completed
494 enrolled